These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6130069)

  • 1. Notes on buspirone's mechanisms of action.
    Garattini S; Caccia S; Mennini T
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):19-24. PubMed ID: 6130069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone: chemistry, pharmacology, and behavior.
    Skolnick P; Paul SM
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):40-4. PubMed ID: 6130072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buspirone: chemical profile of a new class of anxioselective agents.
    Temple DL; Yevich JP; New JS
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):4-10. PubMed ID: 6185470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buspirone, a novel nonbenzodiazepine anxiolytic.
    Kastenholz KV; Crismon ML
    Clin Pharm; 1984; 3(6):600-7. PubMed ID: 6150781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropharmacological profile of buspirone: a non-benzodiazepine anxiolytic with specific mid-brain modulating properties.
    Leonard BE
    Br J Clin Pract Suppl; 1985 May; 38():74-82. PubMed ID: 2862907
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacology and neurochemistry of buspirone.
    Riblet LA; Taylor DP; Eison MS; Stanton HC
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):11-8. PubMed ID: 6130068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical effects of buspirone, a novel psychotropic drug, on the central cholinergic system.
    Kolasa K; Fusi R; Garattini S; Consolo S; Ladinsky H
    J Pharm Pharmacol; 1982 May; 34(5):314-7. PubMed ID: 6123570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical pharmacology of buspirone hydrochloride.
    Skolnick P; Paul SM; Weissman BA
    Pharmacotherapy; 1984; 4(6):308-14. PubMed ID: 6151169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
    Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy.
    Haleem DJ; Shireen E; Haleem MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1323-9. PubMed ID: 15588759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective effects of buspirone and molindone on dopamine metabolism and function in the striatum and frontal cortex of the rat.
    McMillen BA; McDonald CC
    Neuropharmacology; 1983 Mar; 22(3):273-8. PubMed ID: 6133232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics, brain uptake, and receptor binding of tandospirone and its metabolite 1-(2-pyrimidinyl)-piperazine.
    Miller LG; Thompson ML; Byrnes JJ; Greenblatt DJ; Shemer A
    J Clin Psychopharmacol; 1992 Oct; 12(5):341-5. PubMed ID: 1362206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical effects of buspirone in rat hippocampus: evidence for selective activation of 5HT neurons.
    Mennini T; Gobbi M; Ponzio F; Garattini S
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):40-9. PubMed ID: 2421657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats.
    Kääriäinen TM; Lehtonen M; Forsberg MM; Savolainen J; Käenmäki M; Männistö PT
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):50-8. PubMed ID: 17971064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effect of buspirone and 1-(2-pyrimidinyl)-piperazine on cerebral glucose utilization in the rat.
    Grasby P; Sharp T; Moorman J; Grahame-Smith D
    Eur J Pharmacol; 1993 Jan; 230(1):41-6. PubMed ID: 8094054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic mechanisms in the behavioral effects of buspirone and gepirone.
    Eison AS; Eison MS; Stanley M; Riblet LA
    Pharmacol Biochem Behav; 1986 Mar; 24(3):701-7. PubMed ID: 2871564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and man.
    Meltzer HY; Fleming R
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):76-9. PubMed ID: 6130077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azapirones: history of development.
    Eison AS
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):2S-5S. PubMed ID: 1973936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buspirone's advantages over benzodiazepine anxiolytics.
    Ereshefsky L
    Clin Pharm; 1984; 3(6):654-5. PubMed ID: 6150783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.